Return to Trial Database

HCRN-LYM22-565

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-LYM22-565 being conducted in.

Barbara Ann Karmanos Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

University of Virginia Cancer Center